Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology

Vaccine

Volumn 27, Issue 5, 2009, Pages 741-747

  Mattion, Nora ^a,f   Goris, Nesya ^b   Willems, Tom ^b   Robiolo, Blanca ^a,f   Maradei, Eduardo ^c,f   Beascoechea, Claudia Perez ^c,f   Perez, Alejandro ^c,f   Smitsaart, Eliana ^e,f   Fondevila, Norberto ^d,f   Palma, Eduardo ^f   De Clercq, Kris ^b   La Torre, José ^a,f  

^a CONICET ^*  (Argentina)

^b VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^c Servicio Nacional de Sanidad y Calidad Agroalimentaria Argentina   (Argentina)

^d INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^e Biogenesis Bago   (Argentina)

^f Argentine FMD Interinstitutional Network for Research and Development in Foot and mouth Disease (RII   (Argentina)

Author keywords

Foot and mouth disease; r Value; Serology; Vaccine matching

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE;

ARTICLE; FOOT AND MOUTH DISEASE VIRUS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ARGENTINA; CATTLE; CROSS REACTIONS; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNOASSAY; NEUTRALIZATION TESTS; VIRAL VACCINES;

EID: 58249118014     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.026     Document Type: Article

References (20)

1. World Organisation for Animal Health. World Animal Health Information Database Interface, 2008. Available at http://www.oie.int/wahidprod/public.php?page=home.
2. Lombard M., and Fussel A.E. Antigen and vaccine banks: technical requirements and the role of the European antigen bank in emergency foot and mouth disease vaccination. Rev Sci Tech 26 1 (2007) 117-134
3. Paton D.J., Valarcher J.F., Bergmann I., Matlho O.G., Zakharov V.M., Palma E.L., et al. Selection of foot and mouth disease vaccine strains-a review. Rev Sci Tech 24 3 (2005) 981-993
4. Goris N., Merkelbach-Peters P., Diev V.I., Verloo D., Zakharov V.M., Kraft H.P., et al. European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences. Vaccine 25 17 (2007) 3373-3379
5. Goris N., Maradei E., D'Aloia R., Fondevila N., Mattion N., Perez A., et al. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test. Vaccine 26 (2008) 3432-3437
6. McCullough K.C., De Simone F., Brocchi E., Capucci L., Crowther J.R., and Kihm U. Protective immune response against foot-and-mouth disease. J Virol 66 4 (1992) 1835-1840
7. Brehm K.E., Kumar N., Thulke H.H., and Haas B. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 26 13 (2008) 1681-1687
8. Kitching R.P., Rendle R., and Ferris N.P. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus. Vaccine 6 (1988) 403-408
9. Mattion N., König G., Seki C., Smitsaart E., Maradei E., Robiolo B., et al. Reintroduction of foot-and-mouth disease in Argentina: characterization of the isolates and development of tools for the control and eradication of the disease. Vaccine 22 (2004) 4149-4162
10. König G.A., Palma E.L., Maradei E., and Piccone M.E. Molecular epidemiology of foot-and-mouth disease virus types A and O isolated in Argentina during the 2000-2002 epizootic. Vet Microbiol 124 1-2 (2007) 1-15
11. Animal Health Service (SENASA). Act No. 351/2006. Boletín Oficial No. 30.940, Argentina; July 5, 2006 (available at http://infoleg.mecon.gov.ar/infolegInternet/anexos/115000-119999/117636/ norma.htm).
12. Goris N., Willems T., Diev V., Merkelbach-Peters P., Vanbinst T., Van der Stede Y., et al. Indirect foot-and-mouth disease potency testing based on a serological alternative. Vaccine 26 (2008) 3870-3879
13. Periolo O.H., Seki C., Grigera P.R., Robiolo B., Fernandez G., Maradei E., et al. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina. Vaccine 11 (1993) 754-760
14. Robiolo B., Grigera P.R., Periolo O.H., Seki C., Bianchi T., Maradei E., et al. Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina. Vaccine 13 (1995) 1346-1352
15. World Organisation for Animal Health. Foot and mouth disease. OIE Standards Commission. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 6th ed. (2008), Office International des Epizooties, Paris, France Chapter 2.1.5
16. Ferris N.P., and Donaldson A.I. The World Reference Laboratory for Foot and Mouth Disease: a review of thirty-three years of activity (1958-1991). Rev Sci Tech 11 3 (1992) 657-684
17. Rweyemamu M.M. Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction. J Biol Stand 12 3 (1984) 323-337
18. Pan-American Foot-and-Mouth Disease Center. Report on the "Subproyecto para la correlación de las técnicas de control de potencia de las vacunas contra la Fiebre Aftosa en los países de la Cuenca del Río de la Plata". PANAFTOSA, Rio de Janeiro, Brazil; 1994.
19. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., et al. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 24 16 (2006) 3184-3190
20. Robiolo B., Seki C., Fondevilla N., Grigera P., Scodeller E., Periolo O., et al. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA. Vaccine 24 (2006) 997-1008